Boai NKY Medical Holdings Ltd. (300109.SZ) has a MoatMap StockRank of 49/100 based on Quality (66/100), Value (30/100), and Momentum (39/100) factor scores. The current signal is HOLD. Though showing decent quality metrics, this Chinese medical polymer manufacturer lacks a global pricing power moat and faces domestic economic headwinds.
Boai NKY Medical Holdings Ltd. manufactures polyvinylpyrrolidone (PVP) specialty polymers and provides molecular diagnostic services for early cancer screening. The company is the largest PVP producer in China and the third largest globally, serving the pharmaceutical, cosmetics, and industrial beverage sectors. Its dual-engine growth strategy combines a highly profitable, high-barrier chemical business with high-growth medical diagnostics.
| Price | $2.50 |
| Market Cap | $1.3B |
| P/E (TTM) | 47.34 |
| Price/Book | 2.16 |
| Return on Equity | 4.7% |
| Return on Invested Capital | 6.3% |
| Debt/Equity | 8.96 |
| Gross Margin | 45.6% |
| Operating Margin | 23.5% |
| Revenue Growth | 5.3% |
| Dividend Yield | 1.5% |
| Free Cash Flow | $4M |
Boai NKY Medical Holdings Ltd. operates in the Specialty Chemicals industry, part of the Basic Materials sector (China).